FOXA1 and breast carcinoma: Genome-wide chromatin recruitment, chromatin openness, and transcriptional networks in breast cancer models with frequent FOXA1 mutations found that patients with these mutations had unique chromatin characteristics and did not respond well to AI therapy [105].